2025 年 1 月 10 日
RADNOR, PA. – 2025 年 1 月 10 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, today announced the appointment of Tiffany Woodworth as Head of Biometrics, Data Science and Access. This strategic appointment underlines Certara’s commitment to advancing its capabilities in modeling and simulation, regulatory science, and market access. In this role, she will lead the biostatistics, statistical programming, PK/PD programming, advanced analytics, data science, market access and real-world evidence teams at Certara.
Ms. Woodworth has 19 years of leadership experience in the Life Sciences industry, successfully steering teams through strategic growth and operational excellence. She joins Certara from Panalgo, where she served as President and General Manager, delivering significant revenue growth and profitability. She received her MPH at Boston University School of Public Health and her MBA from the Fox School of Business at Temple University.
“Certara’s mission to accelerate medicines to patients through innovation aligns perfectly with my own career principles, as does the talented team of colleagues I’ll be working alongside,” said Tiffany Woodworth. “I’m excited to lead the Biometrics, Data Science and Access team and further expand our ability to deliver cutting-edge solutions that improve global healthcare.”
Patrick Smith, President, Certara Drug Development Solutions, commented, “Tiffany’s leadership and proven track record in biometrics and data science make her a valuable asset to our team. We are enthusiastic about the role she’ll play in helping us deliver solutions that help our clients develop safer, more effective medicines, faster.”
关于Certara
Certara 致力于通过生物模拟软件、技术和服务加速药物研发，改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 66 个国家的监管机构。Learn more at www.certara.com.
